As a trusted CDMO, we offer comprehensive sustaining engineering services to support medical devices throughout their lifecycle. Our expertise includes managing component obsolescence, design changes, and regulatory updates while ensuring uninterrupted supply and compliance.
We proactively address field issues and drive continuous improvement to enhance product performance and reliability. By optimizing cost, quality, and manufacturability, we help extend product life and maintain consistent excellence in the market.
We provide end-to-end sustaining engineering support to ensure consistent performance, compliance, and reliability across the product lifecycle. Our LCM approach focuses on continuous improvement, design updates, and seamless alignment with evolving regulatory and market needs.
Our VAVE initiatives identify opportunities to optimize cost without compromising quality or performance. Through design refinement, material optimization, and process improvements, we enhance product value and manufacturing efficiency.
Our program management services for sustaining engineering ensure seamless coordination of all lifecycle activities for medical devices. We align cross-functional teams across engineering, quality, regulatory, and supply chain to efficiently manage design changes, obsolescence, and field issues. Through structured planning, risk management, and performance tracking, we maintain compliance while driving continuous improvement.
Cleanroom Assembly & Plastics Manufacturing
ISO Class 7 & 8 environments with production-aligned validation setups ensuring controlled, compliant device assembly at scale.
Reliability Testing & Failure Analysis
Comprehensive validation through reliability testing and root-cause analysis to ensure consistent device performance and lifecycle robustness.
Digital Traceability & Process Validation
SAP-integrated MES enabling end-to-end traceability, combined with tooling, process validation, and metrology for manufacturing control.
DFM, value engineering, and supply chain stabilization enabling sustained manufacturing, reduced costs, and long-term production readiness.
Engineering-led redesign and manufacturing optimization delivering faster lysis, consistent sample processing, and scalable, cost-efficient production for global laboratory workflows.
Engage a manufacturing-led partner to manage lifecycle risk, engineering change, and global supply continuity – with execution discipline.
Medical Device Product Lifecycle Management (PLM) is the structured governance of in-market devices to maintain performance, compliance, and production continuity. It typically includes sustenance engineering, engineering change control, obsolescence management, supply chain continuity, and post-market regulatory sustainment.
Component EOL and supplier phase-outs can disrupt production and trigger redesigns that require controlled verification, validation, and documentation updates. Proactive obsolescence management reduces disruption by monitoring lifecycle risk, qualifying alternatives, and planning redesign and requalification within ISO 13485-aligned controls.
Post-market complaints and field performance trends may require corrective actions, risk file updates, and engineering changes. Lifecycle engineering ensures issues are evaluated systematically, linked to CAPA where applicable, and executed through controlled change workflows to protect compliance and product continuity.
Revalidation risk is the likelihood that a design, material, supplier, or process change will require partial or full verification/validation and may impact regulatory documentation. Managing revalidation risk is essential to prevent unplanned testing cycles, remediation of documentation, and production instability.
MOC is managed through structured change control (ECR/ECO/ECN), risk-based impact assessment, and controlled updates to DHF/DMR/TCF as applicable. Changes are planned to maintain traceability, preserve compliance, and align with market-specific regulatory expectations.
Lifecycle VAVE focuses on engineering optimization that preserves performance, safety, and compliance integrity. Activities are executed through controlled change processes, risk reassessment, and defined verification/validation plans to ensure improvements do not introduce unintended regulatory exposure.
Syrma Johari MedTech executes PLM within active manufacturing environments. This means lifecycle decisions consider tooling, process validation, yield sensitivity, supplier transition realities, and audit implications – ensuring recommendations are grounded in production and compliance realities rather than theoretical optimization.
PLM engagement can begin at any stage – for recurring field issues, component obsolescence risk, supplier transitions, regulatory updates, or product redesign initiatives. Early engagement is particularly valuable when changes may trigger revalidation or market-specific documentation updates.
AI-Powered Assistant
